Evidence map›Paper›PMID 37046643›Full record

ArticleCancers2023

Critical Evaluation of a microRNA-Based Risk Classifier Predicting Cancer-Specific Survival in Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava.

Mischa J Kotlyar, Markus Krebs, Antonio Giovanni Solimando, André Marquardt, Maximilian Burger, Hubert Kübler, Ralf Bargou, Susanne Kneitz, Wolfgang Otto, Johannes Breyer and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Mischa J KotlyarDepartment of Urology and Pediatric Urology, University Hospital Würzburg, 97080 Würzburg, Germany.ORCID 0000-0002-1751-2219
Markus KrebsDepartment of Urology and Pediatric Urology, University Hospital Würzburg, 97080 Würzburg, Germany.ORCID 0000-0002-1154-0964
Antonio Giovanni SolimandoGuido Baccelli Unit of Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area-(DiMePRe-J), School of Medicine, Aldo Moro University of Bari, 70124 Bari, Italy.ORCID 0000-0002-2293-9698
André MarquardtDepartment of Pathology, Klinikum Stuttgart, 70174 Stuttgart, Germany.ORCID 0000-0002-2425-7033
Maximilian BurgerDepartment of Urology, Caritas St. Josef, University of Regensburg Medical Center, 93053 Regensburg, Germany.
Hubert KüblerDepartment of Urology and Pediatric Urology, University Hospital Würzburg, 97080 Würzburg, Germany.
Ralf BargouComprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany.
Susanne KneitzPhysiological Chemistry I, Theodor-Boveri-Institute, Biocenter, University of Würzburg, 97074 Würzburg, Germany.
Wolfgang OttoDepartment of Urology, Caritas St. Josef, University of Regensburg Medical Center, 93053 Regensburg, Germany.
Johannes BreyerDepartment of Urology, Caritas St. Josef, University of Regensburg Medical Center, 93053 Regensburg, Germany.
Daniel C VerghoDepartment of Urology, Caritas St. Josef, University of Regensburg Medical Center, 93053 Regensburg, Germany.
Burkhard KneitzDepartment of Urology and Pediatric Urology, University Hospital Würzburg, 97080 Würzburg, Germany.
Charis KalogirouDepartment of Urology and Pediatric Urology, University Hospital Würzburg, 97080 Würzburg, Germany.
Universitätsklinikum Würzburg · DEUniversity of Regensburg · DEComprehensive Cancer Center Mainfranken · DEIstituto Tumori Bari · ITKlinikum Stuttgart · DEUniversity of Würzburg · DE

Funding

Else Kröner-Fresenius-Stiftung Integrative Clinician Scientist College for Translational Immunology
6 · The paper itself

Abstract

(1) Background: Clear cell renal cell carcinoma extending into the inferior vena cava (ccRCC

Indexed as

biomarkerkidney cancermiRRCCrisk stratificationvenous infiltration

Identifiers

PMID37046643
PMCPMC10093292
OpenAlexW4361008829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.